About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolution of Cancer Therapeutics
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Joseph McGuirk
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Joseph McGuirk
0 views
July 22, 2021
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
2021 Virtual KU Hematology and Medical Oncology Review
43:11
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial…
Feat.
B. Van Tine
25:06
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…
Feat.
E. Wulff-Burchfield
30:04
2021 Virtual KU Hematology and Medical Oncology Review
2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials
Feat.
B. Burtness
09:13
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…
Feat.
B. Burtness
18:15
2021 Virtual KU Hematology and Medical Oncology Review
KUMC Highlights on mCRC: Recent Data on Changes in the SoC
Feat.
W. Sun
06:25
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…
Feat.
S. Abbasi
08:08
2021 Virtual KU Hematology and Medical Oncology Review
2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Gov…
Feat.
S. Abbasi
15:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & B…
Feat.
A. Yacoub
05:01
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…
Feat.
A. Yacoub
10:52
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…
Feat.
A. Abdallah
07:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…
Feat.
A. Abdallah
27:42
2021 Virtual KU Hematology and Medical Oncology Review
CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…
Feat.
J. McGuirk
10:44
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…
Feat.
Q. Khan
08:59
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…
Feat.
Q. Khan
10:17
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…
Feat.
Q. Khan
